1. Home
  2. LAND vs CLLS Comparison

LAND vs CLLS Comparison

Compare LAND & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Land Corporation

LAND

Gladstone Land Corporation

HOLD

Current Price

$11.14

Market Cap

372.3M

Sector

Real Estate

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$3.81

Market Cap

374.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAND
CLLS
Founded
1997
1999
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.3M
374.2M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
LAND
CLLS
Price
$11.14
$3.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
848.7K
40.8K
Earning Date
02-24-2026
03-12-2026
Dividend Yield
5.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,936,000.00
$82,551,000.00
Revenue This Year
N/A
$32.58
Revenue Next Year
$4.39
$20.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
129.04
52 Week Low
$8.47
$1.10
52 Week High
$11.93
$5.48

Technical Indicators

Market Signals
Indicator
LAND
CLLS
Relative Strength Index (RSI) 62.36 44.43
Support Level $10.81 $3.44
Resistance Level $11.33 $3.98
Average True Range (ATR) 0.38 0.20
MACD -0.00 -0.00
Stochastic Oscillator 74.19 36.30

Price Performance

Historical Comparison
LAND
CLLS

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: